Association between Growth Hormone and Insulin-like Growth Factor-1 (IGF-1) Levels, Liver Function and Short-Term Survival of Paediatric Liver Recipients

The growth hormone/insulin-like growth factor-1 (IGF-1) system is an important humoral mediator of liver function with an inherent potential for assessing liver condition and survival prognosis following liver transplantation (LT).Aim. Analysis of associations between growth hormone and IGF-1 levels...

Full description

Bibliographic Details
Main Authors: R. M. Kurabekova, O. M. Tsiroulnikova, I. E. Pashkova, L. V. Makarova, N. P. Mozheiko, A. R. Monakhov, O. P. Shevchenko
Format: Article
Language:Russian
Published: Gastro LLC 2020-09-01
Series:Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:
Online Access:https://www.gastro-j.ru/jour/article/view/456
_version_ 1797245192737128448
author R. M. Kurabekova
O. M. Tsiroulnikova
I. E. Pashkova
L. V. Makarova
N. P. Mozheiko
A. R. Monakhov
O. P. Shevchenko
author_facet R. M. Kurabekova
O. M. Tsiroulnikova
I. E. Pashkova
L. V. Makarova
N. P. Mozheiko
A. R. Monakhov
O. P. Shevchenko
author_sort R. M. Kurabekova
collection DOAJ
description The growth hormone/insulin-like growth factor-1 (IGF-1) system is an important humoral mediator of liver function with an inherent potential for assessing liver condition and survival prognosis following liver transplantation (LT).Aim. Analysis of associations between growth hormone and IGF-1 levels in blood and markers of liver function and post-LT survival in children.Materials and methods. We examined 143 children with end-stage liver disease (ESLD) aged 3 to 73 (median 8) months after related LT. The growth hormone and IGF-1 concentrations in plasma were evaluated in ELISA assays. Results. In children with ESLD, concentrations of growth hormone and IGF-1 were significantly higher and lower, respectively, compared to healthy children of the same age (p <0.01). Compared to the level of growth hormone, the level of IGF-1 was related to the diagnosis (r = 0.30, p = 0.004). IGF-1 shows lower concentrations in biliary atresia and other cholestatic liver diseases compared to non-cholestatic aetiologies (4.7 (0.0—23.4) and 42.3 (9.0—55.0) ng/mL, respectively, p = 0.03). The growth hormone level directly correlated with the severity of liver fibrosis (r = 0.47, p = 0.02). It was higher in fibrosis grade 4 (F4) than in F1—F3 (4.7 (2.1—7.2) and 2.1 (1.2—3.3) ng/mL, respectively, p = 0.02). Hormone levels normalised after LT. Unlike IGF-1, the level of growth hormone correlated one month after LT with the 6-months survival rate of recipients (r = 0.36, p = 0.01) being significantly lower in survivors compared to patients who did not survive this period (1.3 (0.5—1.9) and 2.9 (1.6—12.4) ng/mL, respectively, p = 0.02).Conclusion. Blood levels of growth hormone and IGF-1 were shown to differ significantly between ESLD and healthy children, correlating with fibrosis severity and disease aetiology. The level of growth hormone in the blood of LT recipients associates with a short-term survival rate.
first_indexed 2024-03-08T09:20:57Z
format Article
id doaj.art-61c381299c3b40899277996bc7e6e826
institution Directory Open Access Journal
issn 1382-4376
2658-6673
language Russian
last_indexed 2024-04-24T19:23:00Z
publishDate 2020-09-01
publisher Gastro LLC
record_format Article
series Российский журнал гастроэнтерологии, гепатологии, колопроктологии
spelling doaj.art-61c381299c3b40899277996bc7e6e8262024-03-25T16:53:09ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732020-09-01304445110.22416/1382-4376-2020-30-4-44-51377Association between Growth Hormone and Insulin-like Growth Factor-1 (IGF-1) Levels, Liver Function and Short-Term Survival of Paediatric Liver RecipientsR. M. Kurabekova0O. M. Tsiroulnikova1I. E. Pashkova2L. V. Makarova3N. P. Mozheiko4A. R. Monakhov5O. P. Shevchenko6Shumakov National Medical Research Centre for Transplantology and Artificial OrgansShumakov National Medical Research Centre for Transplantology and Artificial Organs; Sechenov First Moscow State Medical University (Sechenov University)Shumakov National Medical Research Centre for Transplantology and Artificial OrgansShumakov National Medical Research Centre for Transplantology and Artificial OrgansShumakov National Medical Research Centre for Transplantology and Artificial OrgansShumakov National Medical Research Centre for Transplantology and Artificial OrgansShumakov National Medical Research Centre for Transplantology and Artificial Organs; Sechenov First Moscow State Medical University (Sechenov University)The growth hormone/insulin-like growth factor-1 (IGF-1) system is an important humoral mediator of liver function with an inherent potential for assessing liver condition and survival prognosis following liver transplantation (LT).Aim. Analysis of associations between growth hormone and IGF-1 levels in blood and markers of liver function and post-LT survival in children.Materials and methods. We examined 143 children with end-stage liver disease (ESLD) aged 3 to 73 (median 8) months after related LT. The growth hormone and IGF-1 concentrations in plasma were evaluated in ELISA assays. Results. In children with ESLD, concentrations of growth hormone and IGF-1 were significantly higher and lower, respectively, compared to healthy children of the same age (p <0.01). Compared to the level of growth hormone, the level of IGF-1 was related to the diagnosis (r = 0.30, p = 0.004). IGF-1 shows lower concentrations in biliary atresia and other cholestatic liver diseases compared to non-cholestatic aetiologies (4.7 (0.0—23.4) and 42.3 (9.0—55.0) ng/mL, respectively, p = 0.03). The growth hormone level directly correlated with the severity of liver fibrosis (r = 0.47, p = 0.02). It was higher in fibrosis grade 4 (F4) than in F1—F3 (4.7 (2.1—7.2) and 2.1 (1.2—3.3) ng/mL, respectively, p = 0.02). Hormone levels normalised after LT. Unlike IGF-1, the level of growth hormone correlated one month after LT with the 6-months survival rate of recipients (r = 0.36, p = 0.01) being significantly lower in survivors compared to patients who did not survive this period (1.3 (0.5—1.9) and 2.9 (1.6—12.4) ng/mL, respectively, p = 0.02).Conclusion. Blood levels of growth hormone and IGF-1 were shown to differ significantly between ESLD and healthy children, correlating with fibrosis severity and disease aetiology. The level of growth hormone in the blood of LT recipients associates with a short-term survival rate.https://www.gastro-j.ru/jour/article/view/456growth hormoneinsulin-like growth factor-1liver fibrosispaediatric liver recipientsliver transplantation
spellingShingle R. M. Kurabekova
O. M. Tsiroulnikova
I. E. Pashkova
L. V. Makarova
N. P. Mozheiko
A. R. Monakhov
O. P. Shevchenko
Association between Growth Hormone and Insulin-like Growth Factor-1 (IGF-1) Levels, Liver Function and Short-Term Survival of Paediatric Liver Recipients
Российский журнал гастроэнтерологии, гепатологии, колопроктологии
growth hormone
insulin-like growth factor-1
liver fibrosis
paediatric liver recipients
liver transplantation
title Association between Growth Hormone and Insulin-like Growth Factor-1 (IGF-1) Levels, Liver Function and Short-Term Survival of Paediatric Liver Recipients
title_full Association between Growth Hormone and Insulin-like Growth Factor-1 (IGF-1) Levels, Liver Function and Short-Term Survival of Paediatric Liver Recipients
title_fullStr Association between Growth Hormone and Insulin-like Growth Factor-1 (IGF-1) Levels, Liver Function and Short-Term Survival of Paediatric Liver Recipients
title_full_unstemmed Association between Growth Hormone and Insulin-like Growth Factor-1 (IGF-1) Levels, Liver Function and Short-Term Survival of Paediatric Liver Recipients
title_short Association between Growth Hormone and Insulin-like Growth Factor-1 (IGF-1) Levels, Liver Function and Short-Term Survival of Paediatric Liver Recipients
title_sort association between growth hormone and insulin like growth factor 1 igf 1 levels liver function and short term survival of paediatric liver recipients
topic growth hormone
insulin-like growth factor-1
liver fibrosis
paediatric liver recipients
liver transplantation
url https://www.gastro-j.ru/jour/article/view/456
work_keys_str_mv AT rmkurabekova associationbetweengrowthhormoneandinsulinlikegrowthfactor1igf1levelsliverfunctionandshorttermsurvivalofpaediatricliverrecipients
AT omtsiroulnikova associationbetweengrowthhormoneandinsulinlikegrowthfactor1igf1levelsliverfunctionandshorttermsurvivalofpaediatricliverrecipients
AT iepashkova associationbetweengrowthhormoneandinsulinlikegrowthfactor1igf1levelsliverfunctionandshorttermsurvivalofpaediatricliverrecipients
AT lvmakarova associationbetweengrowthhormoneandinsulinlikegrowthfactor1igf1levelsliverfunctionandshorttermsurvivalofpaediatricliverrecipients
AT npmozheiko associationbetweengrowthhormoneandinsulinlikegrowthfactor1igf1levelsliverfunctionandshorttermsurvivalofpaediatricliverrecipients
AT armonakhov associationbetweengrowthhormoneandinsulinlikegrowthfactor1igf1levelsliverfunctionandshorttermsurvivalofpaediatricliverrecipients
AT opshevchenko associationbetweengrowthhormoneandinsulinlikegrowthfactor1igf1levelsliverfunctionandshorttermsurvivalofpaediatricliverrecipients